Registration - Organization

Amgen Canada Inc. / Ugur Gunaydin, General Manager, Canada

Registration Information

Organization name: Amgen Canada Inc.
Senior Officer Name: Ugur Gunaydin, General Manager, Canada
Senior Officer Change History
Initial registration start date: 2010-04-07
Registration status: Active
Projected end date: No date provided
Registration number: 8948-138

Associated Lobbying Activity Reports

Total number of Lobbying Activity Reports: 20

Lobbying Activity Reports - last 6 months: 4

Version 34 of 35 (2024-08-30 to 2024-09-10)

Registration versions:

Version 34 of 35 (2024-08-30 to 2024-09-10)

Lobbying Information

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Subject matters added through an Lobbying Activity Report:
Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Communicating with government officials, in general, about the pharmaceutical sector.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Science and Technology
Communicating with government officials, in general, about the pharmaceutical sector in British Columbia. The goal of these communications is (i) to keep the provincial government informed of general industry developments, initiatives and trends and (ii) to explore potential collaboration, in general, between industry and the provincial government.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Science and Technology
Communicating with government officials about policies and programs designed to support innovative research and development in the pharmaceutical sector.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Communicating with government officials about the Government of British Columbia's "Life Sciences and Biomanufacturing Strategy".	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Science and Technology
Communicating with government officials about the Government of British Columbia's "Pharmaceutical Care Management Strategy".	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Communicating with government officials about the listing of Amgen's products for reimbursement purposes.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Health
Subject matters added through an Lobbying Activity Report:
Communicating with government officials about improvements to approval processes for pharmaceuticals, including (i) streamlining rare disease drug review processes and (ii) harmonizing clinical trials and research ethics reviews.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Communicating with government officials about policies and programs designed to support innovative research and development in the pharmaceutical sector.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health

BC Ministries/Provincial Entities

Health
Innovate BC
Jobs, Economic Development and Innovation
Member(s) of the BC Legislative Assembly
Post-Secondary Education and Future Skills
Provincial Health Services Authority

Organization Details

Senior Officer Name and Position during the Period of this Registration

Ugur Gunaydin, General Manager, Canada

Organization Contact Information

Amgen Canada Inc.

Address:
6775 Financial Drive, Suite 100
Mississauga, ON L5N 0A4
Canada

Telephone number: 905-285-3000
Fax number: 905-285-3100

Description of Activities

Scientific affairs, commercial operations and administrative activities in biotechnology and pharmaceutical sector.

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Contributors to the Lobbying Activity

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.

Government Funding in the Last 12 Months

No government funding was requested or received within the preceding 12 months.

Coalition Members Information

Amgen Canada Inc. is not a coalition member.

Affiliates with a Direct Interest in the Outcome

Amgen Inc.
- One Amgen Center Drive
  Thousand Oaks, CA 91320-1799
  United States of America

Other Persons or Organizations with Direct Interests

The activities of Amgen Canada Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.

Lobbyists Details

Lobbyists Employed by this Organization

Lobbyist

Contributions

Angela Behboodi
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No